Cargando…
A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries
Organic cation transporter (OCT) function is critical for cellular homeostasis. C. elegans lacking OCT-1 displays a shortened lifespan and increased susceptibility to oxidative stress. We show that these phenotypes can be rescued by downregulating the OCT-1 paralogue, OCT-2. Herein, we delineate a b...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081529/ https://www.ncbi.nlm.nih.gov/pubmed/27786254 http://dx.doi.org/10.1038/srep36026 |
_version_ | 1782462914111733760 |
---|---|
author | Papaluca, Arturo Ramotar, Dindial |
author_facet | Papaluca, Arturo Ramotar, Dindial |
author_sort | Papaluca, Arturo |
collection | PubMed |
description | Organic cation transporter (OCT) function is critical for cellular homeostasis. C. elegans lacking OCT-1 displays a shortened lifespan and increased susceptibility to oxidative stress. We show that these phenotypes can be rescued by downregulating the OCT-1 paralogue, OCT-2. Herein, we delineate a biochemical pathway in C. elegans where uptake of genotoxic chemotherapeutics such as doxorubicin and cisplatin, and subsequent DNA damage-induced apoptosis of germ cells, are dependent exclusively upon OCT-2. We characterized OCT-2 as the main uptake transporter for doxorubicin, as well as a number of other therapeutic agents and chemical compounds, some identified through ligand-protein docking analyses. We provide insights into the conserved features of the structure and function and gene regulation of oct-1 and oct-2 in distinct tissues of C. elegans. Importantly, our innovative approach of exploiting C. elegans uptake transporters in combination with defective DNA repair pathways will have broad applications in medicinal chemistry. |
format | Online Article Text |
id | pubmed-5081529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50815292016-10-31 A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries Papaluca, Arturo Ramotar, Dindial Sci Rep Article Organic cation transporter (OCT) function is critical for cellular homeostasis. C. elegans lacking OCT-1 displays a shortened lifespan and increased susceptibility to oxidative stress. We show that these phenotypes can be rescued by downregulating the OCT-1 paralogue, OCT-2. Herein, we delineate a biochemical pathway in C. elegans where uptake of genotoxic chemotherapeutics such as doxorubicin and cisplatin, and subsequent DNA damage-induced apoptosis of germ cells, are dependent exclusively upon OCT-2. We characterized OCT-2 as the main uptake transporter for doxorubicin, as well as a number of other therapeutic agents and chemical compounds, some identified through ligand-protein docking analyses. We provide insights into the conserved features of the structure and function and gene regulation of oct-1 and oct-2 in distinct tissues of C. elegans. Importantly, our innovative approach of exploiting C. elegans uptake transporters in combination with defective DNA repair pathways will have broad applications in medicinal chemistry. Nature Publishing Group 2016-10-27 /pmc/articles/PMC5081529/ /pubmed/27786254 http://dx.doi.org/10.1038/srep36026 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Papaluca, Arturo Ramotar, Dindial A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title_full | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title_fullStr | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title_full_unstemmed | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title_short | A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
title_sort | novel approach using c. elegans dna damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081529/ https://www.ncbi.nlm.nih.gov/pubmed/27786254 http://dx.doi.org/10.1038/srep36026 |
work_keys_str_mv | AT papalucaarturo anovelapproachusingcelegansdnadamageinducedapoptosistocharacterizethedynamicsofuptaketransportersfortherapeuticdrugdiscoveries AT ramotardindial anovelapproachusingcelegansdnadamageinducedapoptosistocharacterizethedynamicsofuptaketransportersfortherapeuticdrugdiscoveries AT papalucaarturo novelapproachusingcelegansdnadamageinducedapoptosistocharacterizethedynamicsofuptaketransportersfortherapeuticdrugdiscoveries AT ramotardindial novelapproachusingcelegansdnadamageinducedapoptosistocharacterizethedynamicsofuptaketransportersfortherapeuticdrugdiscoveries |